home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.96 +0.42 (+1.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

31 32 Next >

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 07, 2024

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 07, 2024

Via Benzinga

Why Viking Therapeutics Stock Is Plunging Today ↗

March 07, 2024

The sell-off could present a buying opportunity for aggressive investors willing to bet that the obesity market will be big enough for multiple winners.

Via The Motley Fool

Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗

February 29, 2024

Via Benzinga

Behind the Scenes of Viking Therapeutics's Latest Options Trends ↗

February 28, 2024

Via Benzinga

Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug ↗

March 07, 2024

Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

March 06, 2024

Via Benzinga

Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant

March 06, 2024

The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher

Via MarketBeat

Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News? ↗

March 06, 2024

A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings.

Via The Motley Fool

A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried? ↗

March 05, 2024

Here's why I'm not worried.

Via The Motley Fool

Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly ↗

March 05, 2024

One is a reigning champion, and the other is a burgeoning contender.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

March 04, 2024

Via Benzinga

1 Wall Street Analyst Thinks Viking Therapeutics Stock Is Going to $116. Is It a Buy Around $81? ↗

March 04, 2024

It could have even further to rise after its massive run-up.

Via The Motley Fool

Beyond the "Mag 7": 3 Risk-On Market Forces ↗

March 03, 2024

The biggest bear argument over the past year has been slim leadership in the market, namely concentrated in mega-cap tech stocks such as the “Mag 7.” However, dig deeper, and you will discover there's...

Via Talk Markets

Better Buy: Eli Lilly vs. Viking Therapeutics ↗

March 03, 2024

These two biotechs could eventually go head to head in a fast-growing market.

Via The Motley Fool

Missed Out on Novo Nordisk Stock? Buy This 1 Biotech Stock Right Now. ↗

March 03, 2024

The battle for the obesity therapies market is escalating.

Via The Motley Fool

Why Novo Nordisk Stock Topped the Market Today ↗

March 01, 2024

A favorite of both investors and analysts gets a boost from a bullish move by a pundit.

Via The Motley Fool

Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review ↗

March 01, 2024

The Nasdaq is on the cusp of setting a record high.

Via Investor's Business Daily

Topics Economy

Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion ↗

March 01, 2024

Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.

Via Investor's Business Daily

2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years ↗

March 01, 2024

It will take a lot, but this goal isn't out of reach for these stocks.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 29, 2024

Via Benzinga

Viking Therapeutics: A Teachable Moment About Investing for the Long Term ↗

February 29, 2024

The biotherapeutics company's weight loss candidate scored a major win this week.

Via The Motley Fool

Viking Therapeutics Just Soared 120% on Optimism About Its Weight Loss Candidate. Too Late to Buy? ↗

February 29, 2024

Viking stock surged in the triple digits in one trading session.

Via The Motley Fool

Is Viking Therapeutics a Buy Now? ↗

February 29, 2024

The stock recently jumped more than 100% overnight thanks to surprising results from its anti-obesity candidate.

Via The Motley Fool

Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue? ↗

February 28, 2024

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of 2021. David Prince, professional trader at T3 Trading Group, joined...

Via Benzinga

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares? ↗

February 28, 2024

The company reported in-line sales for the fourth quarter, but shares soared by double digits.

Via Investor's Business Daily

Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say ↗

February 28, 2024

Viking Therapeutics achieves significant weight loss in the VENTURE trial, outperforming rivals in body weight reductions.

Via Benzinga

Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag' ↗

February 28, 2024

During Tuesday's CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer...

Via Benzinga

Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

February 27, 2024

The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling by 0.25% to 38,972.41.

Via Benzinga

Topics Stocks

Why Novo Nordisk and Eli Lilly Stocks Slipped Today ↗

February 27, 2024

A competitor to Wegovy and Zepbound might appear on pharmacy shelves before long.

Via The Motley Fool

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com